- Home
- USAU vs PALI Comparison
USAU vs PALI Comparison
Compare USAU & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.16
HOLD
Current Price
$1.89
Company Overview
Basic Information| Metric | USAU | PALI |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.5M | 240.2M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | USAU | PALI |
|---|---|---|
| Price | $14.16 | $1.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $22.83 | $13.00 |
| AVG Volume (30 Days) | 277.8K | ★ 2.9M |
| Earning Date | 03-16-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,402,000.00 | $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $7.38 | $0.55 |
| 52 Week High | $23.72 | $2.64 |
Technical Indicators
Market Signals| Indicator | USAU | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 32.57 | 51.89 |
| Support Level | $12.06 | $1.58 |
| Resistance Level | $14.39 | $1.93 |
| Average True Range (ATR) | 0.97 | 0.12 |
| MACD | -0.42 | 0.02 |
| Stochastic Oscillator | 1.46 | 56.72 |
Price Performance
Historical Comparison USAU
PALI
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.